Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Incidence, Risk Association and Outcomes of Adult Transplant Associated Thrombotic Microangiopathy By Applying Modified Jodele Criteria - a Single Center Experience

Meghana Vivek, Laura Connelly-Smith, Sandhya R. Panch

Blood (2024) 144 (Supplement 1): 7300.

https://doi.org/10.1182/blood-2024-211370

Published: 2024

Journal Articles

Trials in Progress: Decoy-Resistant Interleukin-18 (DR-18) for Relapse or Pre-Emptive Treatment of Measurable Residual Disease after Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome (DR. DREAM), a Phase I Trial

Elizabeth Krakow, Laura Connelly-Smith, Catherine J. Lee, Dow Dunbar, Jeremy Barton, Beatrice P. McQueen, Geoffrey R. Hill, Jacob S. Appelbaum

Blood (2024) 144 (Supplement 1): 4780.1.

https://doi.org/10.1182/blood-2024-204129

Published: 2024

Journal Articles

Effects of Severe Acute Graft-Versus-Host Disease on Quality of Life, Medical Comorbidities and Survival

Nahid Rashid, Albert Yeh, Marco Mielcarek, Masumi Ueda Oshima, Elizabeth F Krakow, Lynn E. Onstad, Laura Connelly-Smith, Phuong Vo, Stephanie J. Lee

Blood (2022) 140 (Supplement 1): 10552–10553.

https://doi.org/10.1182/blood-2022-167820

Published: 2022

Journal Articles

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

Madan Jagasia, Miguel-Angel Perales, Mark A. Schroeder, Haris Ali, Nirav N. Shah, Yi-Bin Chen, Salman Fazal, Fitzroy W. Dawkins, Michael C. Arbushites, Chuan Tian, Laura Connelly-Smith, Michael D. Howell, H. Jean Khoury

Blood (2020) 135 (20): 1739–1749.

https://doi.org/10.1182/blood.2020004823

Published: 2020

Includes: Supplemental data

Journal Articles

P-Glycoprotein Is Downregulated in KG1a Primitive Leukaemia Cells by LDL Cholesterol Deprivation and by HMG-CoA Reductase Inhibitors.

Laura Connelly-Smith, MBBCh, Joanne Pattinson, Martin Grundy, Shili Shang, Claire Seedhouse, PhD, Nigel Russell, MBChB, Monica Pallis, PhD

Blood (2007) 110 (11): 4192.

https://doi.org/10.1182/blood.V110.11.4192.4192

Published: 2007

NARROW

Incidence, Risk Association and Outcomes of Adult Transplant Associated Thrombotic Microangiopathy By Applying Modified Jodele Criteria - a Single Center Experience

Trials in Progress: Decoy-Resistant Interleukin-18 (DR-18) for Relapse or Pre-Emptive Treatment of Measurable Residual Disease after Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome (DR. DREAM), a Phase I Trial

Effects of Severe Acute Graft-Versus-Host Disease on Quality of Life, Medical Comorbidities and Survival

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

P-Glycoprotein Is Downregulated in KG1a Primitive Leukaemia Cells by LDL Cholesterol Deprivation and by HMG-CoA Reductase Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

Incidence, Risk Association and Outcomes of Adult Transplant Associated Thrombotic Microangiopathy By Applying Modified Jodele Criteria - a Single Center Experience

Trials in Progress: Decoy-Resistant Interleukin-18 (DR-18) for Relapse or Pre-Emptive Treatment of Measurable Residual Disease after Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome (DR. DREAM), a Phase I Trial

Effects of Severe Acute Graft-Versus-Host Disease on Quality of Life, Medical Comorbidities and Survival

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

P-Glycoprotein Is Downregulated in KG1a Primitive Leukaemia Cells by LDL Cholesterol Deprivation and by HMG-CoA Reductase Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only